An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R35CA197684-02
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
National Institutes of Health
Grant: 5R01CA218600-05
Targeting Lysine Methyltransferases EZH2 and EZH1 for Treating MLL-rearranged Leukemias
National Institutes of Health
Grant: 7R01CA268519-03
Dissecting and targeting canonical and non-canonical oncogenic functions of EZH2 in caner
National Institutes of Health
Grant: 5F31CA250362-02
EZH2 as a Transcriptional Activator of NF-kappaB in Triple Negative Breast Cancer
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords
Sustainable Development Goals